Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor

Detalles Bibliográficos
Autores principales: Chen, Shumin, Li, Ye, Wang, Zheng, Feng, Lin, Jia, Yueping, Mo, Xiaodong, Wang, Yu, Jiang, Qian, Huang, Xiaojun, Lai, Yueyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309510/
https://www.ncbi.nlm.nih.gov/pubmed/36806200
http://dx.doi.org/10.1097/CM9.0000000000002481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309510/
https://www.ncbi.nlm.nih.gov/pubmed/36806200
http://dx.doi.org/10.1097/CM9.0000000000002481

Ejemplares similares